Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5159266 | 6169989 | F | 2 | 5159266-5 | 20061017 | 20061109 | 20061120 | EXP | 2006SP004704 | SCHERING-PLOUGH CORPORATION | 61 | YR | M | N | 94.3 | KG | 20061117 | MD | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5159266 | 1007887376 | PS | TEMOZOLOMIDE (S-P) (TEMOZOLOMIDE) | 2 | 315 MG, 315 MG, | D | D | 21029 | |||
| 5159266 | 1007917711 | C | KEVATRIL | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5159266 | 1007887376 | METASTATIC MALIGNANT MELANOMA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5159266 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5159266 | PLEURAL EFFUSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5159266 | FGN |
| 5159266 | HP |
| 5159266 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5159266 | 1007887376 | 20061005 | 20061012 | ||
| 5159266 | 1007887376 | 20060805 |